+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Vical Inc - logo

Vical Incorporated is a biopharmaceutical company that develops products based on its DNA delivery technologies for the prevention and treatment of serious or life-threatening diseases. Its product candidates include CyMVectin prophylactic vaccine for cytomegalovirus (CMV), a therapeutic vaccine and prophylactic for herpes simplex virus type 2 and VL-2397 antifungal. The company was founded in 1987 and is headquartered in San Diego, California.

Infectious Vaccine Collaboration and Licensing Deals 2016-2023 - Product Thumbnail Image

Infectious Vaccine Collaboration and Licensing Deals 2016-2023

  • Report
  • November 2023
  • 300 Pages
  • Global
From
Therapeutic Vaccines - Global Strategic Business Report - Product Thumbnail Image

Therapeutic Vaccines - Global Strategic Business Report

  • Report
  • February 2024
  • 182 Pages
  • Global
From
Melanoma Drugs Global Market Report 2024 - Product Thumbnail Image

Melanoma Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
From
Metastatic Melanoma Therapeutics Global Market Report 2024 - Product Thumbnail Image

Metastatic Melanoma Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
Dengue DNA vaccine - Product Thumbnail Image

Dengue DNA vaccine

  • Drug Pipelines
  • January 2018
  • 10 Pages
  • Global
From
From
CAR-T Therapies Market (2nd Edition), 2019-2030 - Product Thumbnail Image

CAR-T Therapies Market (2nd Edition), 2019-2030

  • Report
  • August 2019
  • 580 Pages
  • Global
From
Cytomegalovirus (HHV-5) Infections - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Cytomegalovirus (HHV-5) Infections - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • December 2021
  • 322 Pages
  • Global
From
From
  • 13 Results (Page 1 of 1)
Loading Indicator